Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deoxyglucose SCHEMBL29105105 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL307650 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL148114 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL2315642 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL3019708 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL2065929 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL4480352 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL10386937 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL200714 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL635056 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2368 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3813785-B1 | 5-OXAZOLIDINE-2,4-DIONE C-GLYCOSIDE DERIVATIVES AND THEIR USE AS MOISTURIZER FOR THE SKIN | OREAL (FR) | 2026-05-06 | — | — | EP | claimed |
| WO-2026087556-A1 | CHEMO-ENZYMATIC APPROACH FOR THE SYNTHESIS OF RARE C3- SUGARS EPIMERS USING A GLYCOSIDE 3-OXIDASE (ENGINEERED) ENZYMES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2026-04-30 | — | — | WO | claimed |
| EP-3955935-B1 | ALKYL-TRIPHENYLPHOSPHONIUM (A-TPP) COMPOUNDS IN COMBINATION THERAPY WITH A GLYCOLYSIS INHIBITOR COMPOUND OR AN OXPHOS INHIBITOR COMPOUND FOR MITOCHONDRIA TARGETING AND FOR USE IN ANTI-CANCER TREATMENTS | LUNELLA BIOTECH INC (CA) | 2026-03-18 | — | — | EP | claimed |
| EP-4344398-B1 | SLOW-RELEASE FORMULATION | GLYCOSCIENCE S L (ES) | 2026-02-11 | — | — | EP | claimed |
| EP-3655000-B1 | METHOD FOR PRESERVING BIOPHARMACEUTICALS | UNIVERSAL STABILIZATION TECH INC (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250320175-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-10-16 | — | — | US | claimed |
| EP-4605371-A1 | POLYOL-DERIVED COMPOUNDS | Arxada AG (CH) | 2025-08-27 | — | — | EP | claimed |
| US-20250261676-A1 | FUNGAL BIOMASS AND METHOD OF PRODUCING THEREOF | ENIFERBIO OY (FI) | 2025-08-21 | — | — | US | claimed |
| EP-3976197-B1 | THERAPEUTICS AND METHODS FOR PREDICTING AND OVERCOMING ENDOCRINE RESISTANCE IN BREAST CANCER | LUNELLA BIOTECH INC (CA) | 2025-07-16 | — | — | EP | claimed |
| EP-4582080-A1 | DISPENSER FOR MUCOSAL ADMINISTRATION COMPRISING 2-DEOXY-GLUCOSE OR ANALOGUES THEREOF | G.ST Antivirals GmbH (AT) | 2025-07-09 | — | — | EP | claimed |
| EP-0503320-B1 | Agent or concentrate for the conservation of wood and wooden articles against wood destroying and/or wood degrading and/or cellulose degrading organisms | DESOWAG MATERIALSCHUTZ GMBH (DE) | 1995-12-20 | — | — | EP | claimed |
| EP-0667245-A1 | Recording sheets containing alcohols and saccharides | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| EP-0427843-B1 | SPECIFIC INHIBITOR FOR RETROVIRUS REVERSE TRANSCRIPTASE, AND ITS APPLICATION AS A MEDICAMENT | BLOUGH HERBERT A (US) | 1995-03-08 | — | — | EP | claimed |
| EP-0632813-A1 | AMADORI REACTION COMPOUNDS AND PRODUCTS, PROCESS FOR THEIR MANUFACTURE, AND THEIR USE | Torf Establishment (LI) | 1995-01-11 | — | — | EP | claimed |
| WO-1993016087-A2 | AMADORI REACTION COMPOUNDS AND PRODUCTS, PROCESS FOR THEIR MANUFACTURE, AND THEIR USE | TORF ESTABLISHMENT (LI) | 1993-08-19 | — | — | WO | claimed |
| US-5159067-A | 5'-Diphosphohexose nucleoside pharmaceutical compositions | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (US) | 1992-10-27 | — | — | US | claimed |
| EP-0178602-B1 | TREATMENT FOR TISSUE DEGENERATIVE INFLAMMATORY DISEASE | Peritain, Ltd. (US) | 1992-05-06 | — | — | EP | claimed |
| EP-0427843-A1 | SPECIFIC INHIBITOR FOR RETROVIRUS REVERSE TRANSCRIPTASE, AND ITS APPLICATION AS A MEDICAMENT. | PASTEUR INSTITUT (FR) | 1991-05-22 | — | — | EP | claimed |
| WO-1990014825-A1 | SPECIFIC INHIBITOR FOR RETROVIRUS REVERSE TRANSCRIPTASE, AND ITS APPLICATION AS A MEDICAMENT | INSTITUT PASTEUR (FR) | 1990-12-13 | — | — | WO | claimed |
| EP-0125039-B1 | ENZYMATIC PRODUCTION OF PHOSPHOLIPID-SACCHARIDE DERIVATIVES | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |